Trial Profile
To assess incidence of non-CABG bleeding complications, before and after introduction of ticagrelor in real-life patients with ST-segment elevation myocardial infarction
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Sep 2018
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary)
- Indications Myocardial infarction
- Focus Therapeutic Use
- 19 Sep 2018 New trial record
- 29 Aug 2018 Results presented at the ESC Congress 2018: Annual Congress of the European Society of Cardiology